Data gathered from post sedation questionnaire, specifically question 5, will be analyzed by comparing the two means of group one and group two using a student's T test,
Techniques to Reduce the Severity and Frequency of Emergent Reactions
Brief Summary
Intervention / Treatment
-
Do we speak to them in a way that convinces them to have the dream (BEHAVIORAL)During induction, and depending on what group they are randomized to, the physician will speak to them about having a dream while on the drug
-
Speaking to them as a regualar person (BEHAVIORAL)During induction, if the patient is in group 1, the resident performing procedural sedation will remind the patient about what the patient wanted to dream and ask them to focus on that as the ketamine is being administered. If the patient is in group 2, the resident performing procedural sedation will give no specific instruction to the patient at this point.
Condition or Disease
- Analgesia
Phase
Study Design
Study type: | INTERVENTIONAL |
---|---|
Status: | Terminated |
Study results: | No Results Available |
Age: | 18 Years and older (Adult, Older Adult) |
Enrollment: | 38 (ACTUAL) |
Funded by: | Other |
Allocation: | Randomized |
Primary Purpose: | Other |
MaskingDuring the consent for the study, the physician will do the following depending on which group the patient has been randomized to: Packet 1: The physician will be asked to instruct the patient as empathetically and confidently as possible, that the drug the patient will be given will make them feel not pain, cause them to forget the procedure, and allow them to dream the dream of their choice. The resident will specifically ask the patient what he or she wants to dream about and the resident will then write the patient's answer on the instruction sheet. Packet #2: They physician will be asked to read a written statement about how the drug they will be given will cause analgesia, amnesia, and may cause hallucinations. SINGLE:
|
Clinical Trial Dates
Start date: | Nov 21, 2017 | ACTUAL |
---|---|---|
Primary Completion: | Jun 21, 2021 | ACTUAL |
Completion Date: | Jun 21, 2021 | ACTUAL |
Study First Posted: | Feb 06, 2019 | ACTUAL |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Apr 05, 2022 |
Sponsors / Collaborators
Location
The study will be conducted in the emergency department at CHRISTU Spohn Shoreline Hospital. CHRISTUS Spohn Shore hospital is the region's primary acute care center. It houses the Chest Pain, Stroke, and Cancer Centers of CHRISTUS Spohn, and the only level II trauma center in south Texas. It is a major teaching affiliate of Texas A\&M medical school, and serves an inner-city population.
Participant Groups
-
Packet 1: The Physician will be asked to instruct the patient as empathetically and confidently as possible, that the drug the patient will be given will make them feel no pain, cause them to forget the procedure, and allow them to dream the dream of their choice.
-
Half of the participants will receive the sedation medication with the usual conversation while the physician is giving the medication to the patient. The other half of the participants will have a more positive conversation, (which is the study intervention), with the physician while being given the medication. Both group's emergence reactions, if any, will be compared to see if the positive conversation reduced the side effect.
Eligibility Criteria
Sex: | All |
---|---|
Minimum Age: | 18 |
Age Groups: | Adult / Older Adult |
Healthy Volunteers: | Yes |
* Be at least 18 years of age
* Required need for procedural sedation and analgesia
Exclusion Criteria:
* Age\< 18
* Hypertension
* Raised Intracranial pressure
* Major psychological disorders
* Procedures involving laryngel manipulations
* History of Laryngeal sapsm History of adverse reactions to ketamine
Primary Outcomes
-
-
To ensure two groups are similar to each other -demographic data, the pre and post opt sedation VAS scores, and the STAI-6 information.
More Details
NCT Number: | NCT03832309 |
---|---|
Other IDs: | 2017196 |
Study URL: | https://clinicaltrials.gov/study/NCT03832309 |